| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podocytes | 29 | 2023 | 85 | 5.850 |
Why?
|
| Kidney Diseases | 10 | 2023 | 115 | 2.090 |
Why?
|
| Proteinuria | 14 | 2023 | 81 | 1.650 |
Why?
|
| Diabetic Nephropathies | 5 | 2018 | 27 | 1.130 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 5 | 2023 | 44 | 1.080 |
Why?
|
| Animals | 34 | 2023 | 4577 | 1.000 |
Why?
|
| Kidney | 5 | 2022 | 173 | 1.000 |
Why?
|
| Kidney Failure, Chronic | 3 | 2021 | 161 | 0.950 |
Why?
|
| Glomerulonephritis | 2 | 2020 | 23 | 0.940 |
Why?
|
| Mast Cells | 3 | 2012 | 26 | 0.910 |
Why?
|
| Mice | 26 | 2023 | 1620 | 0.870 |
Why?
|
| Leptin | 2 | 2012 | 22 | 0.830 |
Why?
|
| Cell Separation | 1 | 2021 | 42 | 0.790 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 97 | 0.770 |
Why?
|
| Obesity | 3 | 2012 | 290 | 0.750 |
Why?
|
| Biomarkers | 4 | 2021 | 692 | 0.730 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 6 | 2023 | 41 | 0.690 |
Why?
|
| Phenotype | 3 | 2017 | 357 | 0.650 |
Why?
|
| Actins | 3 | 2017 | 45 | 0.650 |
Why?
|
| Macrophages | 3 | 2017 | 128 | 0.600 |
Why?
|
| Acute Kidney Injury | 3 | 2022 | 49 | 0.570 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 219 | 0.560 |
Why?
|
| Renin | 1 | 2015 | 2 | 0.540 |
Why?
|
| Cell Lineage | 1 | 2015 | 29 | 0.530 |
Why?
|
| Adiposity | 2 | 2012 | 47 | 0.500 |
Why?
|
| Subcutaneous Fat | 2 | 2012 | 10 | 0.500 |
Why?
|
| Kidney Glomerulus | 6 | 2021 | 54 | 0.490 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2022 | 97 | 0.440 |
Why?
|
| TRPC Cation Channels | 5 | 2023 | 11 | 0.430 |
Why?
|
| Abdominal Fat | 1 | 2012 | 10 | 0.420 |
Why?
|
| Adiponectin | 1 | 2011 | 9 | 0.420 |
Why?
|
| Humans | 29 | 2023 | 29361 | 0.410 |
Why?
|
| Cells, Cultured | 9 | 2021 | 676 | 0.410 |
Why?
|
| Lymph Nodes | 1 | 2012 | 70 | 0.410 |
Why?
|
| Integrin alphaVbeta3 | 4 | 2021 | 21 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 432 | 0.380 |
Why?
|
| Intra-Abdominal Fat | 1 | 2010 | 42 | 0.380 |
Why?
|
| Coronary Angiography | 2 | 2021 | 91 | 0.370 |
Why?
|
| Mice, Knockout | 8 | 2021 | 304 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 29 | 0.350 |
Why?
|
| Albuminuria | 4 | 2017 | 21 | 0.340 |
Why?
|
| Dynamins | 4 | 2022 | 10 | 0.330 |
Why?
|
| Cytoskeleton | 4 | 2017 | 51 | 0.320 |
Why?
|
| Epididymis | 3 | 2012 | 8 | 0.310 |
Why?
|
| Apoptosis | 4 | 2017 | 251 | 0.300 |
Why?
|
| Signal Transduction | 8 | 2021 | 483 | 0.300 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2017 | 76 | 0.280 |
Why?
|
| Male | 14 | 2022 | 15637 | 0.280 |
Why?
|
| Aging | 1 | 2015 | 1594 | 0.270 |
Why?
|
| CD11b Antigen | 2 | 2017 | 17 | 0.260 |
Why?
|
| Kidney Tubules | 2 | 2021 | 10 | 0.250 |
Why?
|
| Immunotoxins | 1 | 2023 | 2 | 0.240 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 89 | 0.240 |
Why?
|
| Hyperglycemia | 1 | 2023 | 34 | 0.230 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2023 | 6 | 0.230 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 521 | 0.230 |
Why?
|
| Cytoskeletal Proteins | 2 | 2014 | 21 | 0.220 |
Why?
|
| Glomerular Filtration Rate | 3 | 2019 | 59 | 0.210 |
Why?
|
| Organ Specificity | 2 | 2012 | 47 | 0.210 |
Why?
|
| Iodide Peroxidase | 1 | 2021 | 34 | 0.200 |
Why?
|
| Urography | 1 | 2021 | 4 | 0.200 |
Why?
|
| Urinary Tract | 1 | 2021 | 3 | 0.200 |
Why?
|
| Metabolic Flux Analysis | 1 | 2021 | 1 | 0.200 |
Why?
|
| Cell Respiration | 1 | 2021 | 2 | 0.200 |
Why?
|
| Lactic Acid | 1 | 2021 | 16 | 0.200 |
Why?
|
| Homeostasis | 1 | 2021 | 82 | 0.200 |
Why?
|
| Glycolysis | 1 | 2021 | 21 | 0.200 |
Why?
|
| Oxygen Consumption | 1 | 2021 | 49 | 0.200 |
Why?
|
| Carbon Dioxide | 1 | 2021 | 20 | 0.200 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2021 | 23 | 0.200 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 44 | 0.190 |
Why?
|
| Indoles | 2 | 2017 | 48 | 0.190 |
Why?
|
| Energy Metabolism | 1 | 2021 | 52 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 215 | 0.190 |
Why?
|
| Mitochondria | 1 | 2021 | 79 | 0.190 |
Why?
|
| High-Throughput Screening Assays | 2 | 2017 | 10 | 0.190 |
Why?
|
| Liver | 2 | 2012 | 173 | 0.190 |
Why?
|
| Contrast Media | 1 | 2021 | 125 | 0.190 |
Why?
|
| Mice, Transgenic | 5 | 2023 | 250 | 0.190 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 5 | 0.190 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 42 | 0.180 |
Why?
|
| Inducible T-Cell Co-Stimulator Ligand | 1 | 2019 | 6 | 0.170 |
Why?
|
| Case-Control Studies | 1 | 2021 | 638 | 0.170 |
Why?
|
| United Kingdom | 1 | 2019 | 50 | 0.170 |
Why?
|
| Cell Death | 1 | 2018 | 61 | 0.170 |
Why?
|
| Prognosis | 1 | 2021 | 840 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2016 | 174 | 0.170 |
Why?
|
| Chronic Disease | 1 | 2020 | 495 | 0.170 |
Why?
|
| Membrane Proteins | 2 | 2017 | 173 | 0.160 |
Why?
|
| Nephrons | 1 | 2018 | 6 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 26 | 0.160 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2017 | 2 | 0.160 |
Why?
|
| Renal Agents | 1 | 2017 | 3 | 0.160 |
Why?
|
| Benzazepines | 1 | 2017 | 8 | 0.160 |
Why?
|
| Protective Agents | 1 | 2017 | 9 | 0.160 |
Why?
|
| Female | 9 | 2022 | 16211 | 0.160 |
Why?
|
| Middle Aged | 7 | 2021 | 9823 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 28 | 0.160 |
Why?
|
| Proteome | 1 | 2018 | 39 | 0.160 |
Why?
|
| Drug Discovery | 1 | 2017 | 20 | 0.160 |
Why?
|
| Apolipoproteins | 1 | 2017 | 9 | 0.150 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 11 | 0.150 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 28 | 0.150 |
Why?
|
| Proteomics | 1 | 2018 | 91 | 0.150 |
Why?
|
| Aged | 6 | 2021 | 9447 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 85 | 0.150 |
Why?
|
| Receptor, ErbB-4 | 1 | 2016 | 2 | 0.150 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 28 | 0.150 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 7 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 29 | 0.140 |
Why?
|
| Cell Proliferation | 1 | 2017 | 202 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2016 | 42 | 0.140 |
Why?
|
| Chemokine CCL2 | 2 | 2016 | 20 | 0.140 |
Why?
|
| Cathepsin L | 3 | 2011 | 9 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 137 | 0.140 |
Why?
|
| Doxorubicin | 2 | 2017 | 45 | 0.140 |
Why?
|
| Hydroxyquinolines | 1 | 2015 | 4 | 0.130 |
Why?
|
| Integrin beta1 | 1 | 2015 | 9 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 726 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2015 | 54 | 0.130 |
Why?
|
| Biological Transport, Active | 1 | 2014 | 16 | 0.120 |
Why?
|
| B7-1 Antigen | 1 | 2014 | 12 | 0.120 |
Why?
|
| TRPC6 Cation Channel | 4 | 2023 | 8 | 0.120 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 202 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 148 | 0.120 |
Why?
|
| Complement System Proteins | 1 | 2013 | 15 | 0.120 |
Why?
|
| Iliac Artery | 1 | 2013 | 7 | 0.110 |
Why?
|
| CD18 Antigens | 1 | 2013 | 6 | 0.110 |
Why?
|
| Gene Expression | 2 | 2011 | 226 | 0.110 |
Why?
|
| Adult | 4 | 2021 | 8604 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 441 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 38 | 0.110 |
Why?
|
| Puromycin Aminonucleoside | 3 | 2021 | 7 | 0.110 |
Why?
|
| Glomerular Filtration Barrier | 1 | 2012 | 1 | 0.110 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2012 | 7 | 0.110 |
Why?
|
| Mice, Obese | 1 | 2012 | 6 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2012 | 6 | 0.110 |
Why?
|
| Thymus Gland | 1 | 2012 | 23 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 107 | 0.110 |
Why?
|
| Mastocytosis | 1 | 2011 | 2 | 0.100 |
Why?
|
| Spleen | 1 | 2012 | 51 | 0.100 |
Why?
|
| Tryptases | 1 | 2011 | 8 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2011 | 17 | 0.100 |
Why?
|
| Cell Count | 1 | 2012 | 99 | 0.100 |
Why?
|
| Wound Healing | 1 | 2013 | 168 | 0.100 |
Why?
|
| Cholesterol | 1 | 2012 | 49 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2011 | 36 | 0.100 |
Why?
|
| Organ Size | 1 | 2011 | 107 | 0.100 |
Why?
|
| Random Allocation | 1 | 2011 | 146 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2011 | 112 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2011 | 108 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4851 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2011 | 74 | 0.100 |
Why?
|
| Thinness | 1 | 2010 | 4 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2012 | 112 | 0.100 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2010 | 1 | 0.100 |
Why?
|
| Genome, Mitochondrial | 1 | 2010 | 1 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 14 | 0.100 |
Why?
|
| Actin Cytoskeleton | 2 | 2022 | 13 | 0.090 |
Why?
|
| Proteins | 1 | 2010 | 73 | 0.090 |
Why?
|
| Lipopolysaccharides | 3 | 2017 | 127 | 0.090 |
Why?
|
| Diet | 1 | 2010 | 174 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 349 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 255 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 264 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 50 | 0.080 |
Why?
|
| Cathepsins | 1 | 2007 | 7 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 1 | 2007 | 9 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2021 | 678 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 284 | 0.070 |
Why?
|
| Rats | 3 | 2015 | 858 | 0.070 |
Why?
|
| Time Factors | 2 | 2021 | 1618 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2016 | 31 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2005 | 130 | 0.060 |
Why?
|
| Disease Progression | 2 | 2017 | 788 | 0.060 |
Why?
|
| Insulin | 1 | 2023 | 92 | 0.060 |
Why?
|
| Risk Factors | 2 | 2021 | 2446 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2023 | 157 | 0.050 |
Why?
|
| Receptors, Thyrotropin | 1 | 2021 | 3 | 0.050 |
Why?
|
| Mutation | 3 | 2010 | 383 | 0.050 |
Why?
|
| Thyroid Hormones | 1 | 2021 | 13 | 0.050 |
Why?
|
| Triiodothyronine | 1 | 2021 | 28 | 0.050 |
Why?
|
| Cell Movement | 2 | 2015 | 105 | 0.050 |
Why?
|
| Models, Biological | 2 | 2017 | 344 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 16 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 285 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 453 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 260 | 0.040 |
Why?
|
| Critical Illness | 1 | 2020 | 123 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2011 | 323 | 0.040 |
Why?
|
| Biological Variation, Individual | 1 | 2018 | 1 | 0.040 |
Why?
|
| WT1 Proteins | 1 | 2018 | 1 | 0.040 |
Why?
|
| Proteostasis | 1 | 2018 | 3 | 0.040 |
Why?
|
| Serum Albumin | 1 | 2018 | 24 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2018 | 29 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 7 | 0.040 |
Why?
|
| Sesquiterpenes, Guaiane | 1 | 2017 | 2 | 0.040 |
Why?
|
| Proteolysis | 1 | 2017 | 13 | 0.040 |
Why?
|
| Protein Folding | 1 | 2017 | 18 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2017 | 16 | 0.040 |
Why?
|
| Zebrafish | 1 | 2017 | 21 | 0.040 |
Why?
|
| Piperidines | 1 | 2017 | 32 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 33 | 0.040 |
Why?
|
| Microtubules | 1 | 2017 | 26 | 0.040 |
Why?
|
| Nephrotic Syndrome | 1 | 2018 | 25 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 965 | 0.040 |
Why?
|
| Apolipoprotein L1 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 7 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 14 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2017 | 18 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 127 | 0.040 |
Why?
|
| Integrins | 1 | 2017 | 19 | 0.040 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2017 | 2 | 0.040 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2017 | 2 | 0.040 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2017 | 3 | 0.040 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2020 | 301 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2017 | 18 | 0.040 |
Why?
|
| Cell Line | 1 | 2017 | 299 | 0.040 |
Why?
|
| Ribonucleases | 1 | 2016 | 9 | 0.040 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2016 | 16 | 0.040 |
Why?
|
| Alleles | 1 | 2017 | 224 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 56 | 0.040 |
Why?
|
| Adolescent | 2 | 2017 | 2280 | 0.040 |
Why?
|
| Genotype | 1 | 2017 | 405 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 306 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 788 | 0.030 |
Why?
|
| Focal Adhesions | 1 | 2015 | 9 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 162 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 254 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 116 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 266 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 340 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2015 | 88 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 70 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2014 | 69 | 0.030 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2013 | 6 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2013 | 24 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2013 | 109 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2013 | 5 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 7 | 0.030 |
Why?
|
| K562 Cells | 1 | 2013 | 6 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2013 | 43 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2020 | 957 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 756 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 3476 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2011 | 13 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 1939 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2013 | 174 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2011 | 70 | 0.030 |
Why?
|
| Cell Survival | 1 | 2011 | 169 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 1935 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 22 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 28 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 56 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 3 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2010 | 7 | 0.020 |
Why?
|
| Inflammation | 1 | 2013 | 345 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2010 | 26 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2010 | 28 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 173 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 193 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 246 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 1812 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 199 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2007 | 15 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 35 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 1687 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 125 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 251 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2005 | 4 | 0.020 |
Why?
|
| Pedigree | 1 | 2005 | 77 | 0.020 |
Why?
|